Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

News | PET Imaging

August 19, 2016 — A new non-invasive positron emission tomography (PET) technique can obtain images of neuron ...

Time August 19, 2016
arrow
Technology | Nuclear Imaging

July 28, 2016 — Researchers at the Fraunhofer Institute for Medical Image Computing MEVIS in Bremen, Germany, are ...

Time August 08, 2016
arrow
News | PET Imaging

August 2, 2016 — A cutting-edge method of extracting big data from positron emission tomography (PET) images can provide ...

Time August 02, 2016
arrow
News | Breast Imaging

August 2, 2016 — A retrospective study in American Journal of Roentgenology (AJR) August issue confirmed Gamma Medica’s ...

Time August 02, 2016
arrow
Feature | PET Imaging | Dave Fornell

Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables ...

Time July 26, 2016
arrow
News | SPECT Imaging

July 25, 2016 — UltraSPECT Inc. announced recently that Robert Wood Johnson Physician Enterprise (RWJPE), a multi ...

Time July 25, 2016
arrow
News | Nuclear Imaging

July 19, 2016 - An updated joint American Society of Nuclear Cardiology (ASNC) imaging guidelines and Society of Nuclear ...

Time July 19, 2016
arrow
News | Prostate Cancer

July 14, 2016 — Adding F-18-choline positron emission tomography (PET) to multi-parametric prostate magnetic resonance ...

Time July 14, 2016
arrow
News | Radiopharmaceuticals and Tracers

July 12, 2016 — Lantheus Holdings Inc., the parent company of Lantheus Medical Imaging Inc. (LMI), announced the first ...

Time July 12, 2016
arrow
News | Radiopharmaceuticals and Tracers

July 7, 2016 — Cell>Point announced in mid-June it has entered into an exclusive license agreement for China, Hong Kong ...

Time July 07, 2016
arrow
Feature | Radiology Imaging | Greg Freiherr

Mammography may be the most recognizable — and singularly effective — type of personalized medicine, benefitting from ...

Time July 06, 2016
arrow
Feature | Molecular Imaging | Melinda Taschetta-Millane

I recently attended the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in San ...

Time July 06, 2016
arrow
News | Radiopharmaceuticals and Tracers

July 6, 2016 — Navidea Biopharmaceuticals Inc. announced results from three investigator-initiated studies of the ...

Time July 06, 2016
arrow
News | PET Imaging

June 29, 2016 — Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech ...

Time June 29, 2016
arrow
News | Clinical Decision Support

June 27, 2016 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has been named a qualified provider-led ...

Time June 27, 2016
arrow
News | Nuclear Imaging

June 24, 2016 — Developers of a new portable molecular imaging system debuted their creation at the 2016 Annual Meeting ...

Time June 24, 2016
arrow
News | Oncology Diagnostics

June 23, 2016 — Cancer patients often experience significant fluctuations in weight and lean body mass (LBM). Neglecting ...

Time June 23, 2016
arrow
News | Oncology Diagnostics

June 23, 2016 — Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and ...

Time June 23, 2016
arrow
News | PET Imaging

June 23, 2016 — The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years ...

Time June 23, 2016
arrow
News | Nuclear Imaging

June 23, 2016 — Aggressive neuroendocrine cancer is something of a dark horse — a rare, elusive and persevering force ...

Time June 23, 2016
arrow
Subscribe Now